Baxter’s BioPharma Solutions business, a CMO that specializes in parenteral pharmaceuticals, has completed an 1,800 square meter capacity expansion designed for oncology drugs at its fill/finish contract manufacturing facility in Halle (Westfalen), Germany. The additional capacity for freeze-dried (lyophilized) cytotoxic (having a toxic effect on cells) parenterals supports growing demand for these oncology treatment programs. The sterile manufacturing facility, which includes new equipment c...